🇺🇸 FDA
Patent

US 9101670

Conjugates of an anti-TNF-α antibody

granted A61KA61K2039/6093A61K39/3955

Quick answer

US patent 9101670 (Conjugates of an anti-TNF-α antibody) held by Nektar Therapeutics expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/6093, A61K39/3955, A61K39/44, A61K47/60